HT and breast cancer risk

Fertility and Sterility

Volumn 80, Issue SUPPL. 4, 2003, Pages 5-9

  Geller, Michelle L ^a   Chlebowski, Rowan T ^a,b  

^a Harbor UCLA Res and Educ Institute   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;

BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER INVASION; CANCER RISK; DISEASE DURATION; DRUG MONITORING; ECHOMAMMOGRAPHY; HORMONAL CARCINOGENESIS; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; LYMPH NODE METASTASIS; MEDICAL INFORMATION; MENOPAUSE; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; STROKE; TREATMENT INDICATION;

BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; PROGESTINS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; WOMEN'S HEALTH;

EID: 23744432781     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2003.08.003     Document Type: Review

References (8)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 350:1997;1047-1059
2. Ross R.K., Paganini-Hill A., Wan P.C., Pike M.C. Effect of hormone replacement therapy on breast cancer risk. J Natl Cancer Inst. 92:2000;328-332
3. Chen C.L., Weiss N.S., Newcomb P., Barlow W., White E. Hormone replacement therapy in relation to breast cancer. JAMA. 289:2002;734-741
4. Rossouw E., Anderson G.L., Prentice R.L., et al. for Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative. JAMA. 288:2002;321-333
5. Chlebowski R.T., Hendrix S.L., Langer R.D., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women The Women's Health Initiative randomized trial. JAMA. 289:2003;3243-3253
6. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362;419-27
7. Hays J., Ockene J.K., Brunner R.T., et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 348:2003;1839-1854
8. Harvey J.A., et al. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. J Natl Cancer Inst. 89:1997;1623-1625